What Is Morton's Quick Tender Curing Salt

from monitoring to spying: Infiltration of NGOs and protest groups

The Association of Research-Based Pharmaceutical Companies (VFA) announces today that Chief Executive Cornelia Yzer 1 June 2011 goes. "After 15 labor-intensive and exciting years in an industry whose work is like no other help directly to people, I will now face a new challenge," says the former CDU politician. The successor is not yet known.

Yzer is one of the largest association lobbyists, she was always present in the media, the VFA has become under their leadership campaigns-one association. And a favorite bogeyman the lobby critics . That leaves the Yzer vfa says the WirtschaftsWoche , was "probably not entirely voluntary. The pharmaceutical industry should be modified dissatisfied with her performance was ."

"Every now and then was heard from the industry that Yzer first 'm very confident that will change under the black-yellow government for the pharmaceutical industry little. But then sat Health Minister Rösler mandatory discounts as well as by a new ;. Rösler pricing policy was to ensure that the health insurance future, save more money. But what is good for the patients who annoys the pharmaceutical industry. . Yzer have the risk underestimated , it said "

Spiegel online calls the decision a" bombshell "and writes:

" Companies attributable to the previous CDU-politician above all that the law is to restructure the pharmaceutical market (AMNOG) have completely misjudged . Thus Yzer accused in the industry, they had believed, would taking office with the black-yellow coalition for the pharmaceutical industry even more golden times of dawn . Instead, Health Minister Philippe reformed Rösler (FDP) the drug market radically. The company had to take a mandatory discount on medicines for the benefit of insurance and must accept in future the prices of new innovative medicines to negotiate with the insurance. The influence of VFA in the legislative process was rather modest. ' Yzer a mistake made by one. It was inconceivable that they survived the AMNOG , 'says an insider. "

According to Spiegel online Yzer could switch to the European pharmaceutical industry association EFPIA ." And so the Personnel is really interesting . For a career move, the change from Berlin and Brussels would not be. A senior representative of a pharmaceutical company says: ' you would weggelobt '"

The Medical Journal says:

. The resignation of Yzer is not entirely surprising. For months, is already being speculated Yzer would resign because of continuing criticism of the course of the association. The drug reform, at 1 January 2011, entered into force, provides a number of innovations, the representatives of the pharmaceutical industry cut across the abdomen. (...). The pharmaceutical manufacturers had against these interventions, but especially against the fast evaluation of the benefits of new drugs, up front made last . They fear possible negative repercussions for the Pharma Germany. Companies could from investing in innovative therapies to shrink and lose as a result their guiding function for the European pharmaceutical market. "

2010 had already been going an association manager of the pharmaceutical industry, after a TV interview had become intolerable. See blog entry of Wednesday, May 26 2010: "Pharmaceutical Association ProGenerika satirist Sonneborn goes into the trap"